Core Insights - Catheter Precision, Inc. is set to showcase its LockeT suture retention device at the Structural Heart Intervention and Imaging conference, highlighting its significance in the cardiac electrophysiology market [1][2] Company Overview - Catheter Precision is a U.S.-based medical device company focused on innovative solutions for cardiac arrhythmias, emphasizing collaboration with physicians to advance electrophysiology procedures [4] Product Details - The LockeT device is designed for wound closure after percutaneous venous punctures, classified as a Class 1 device by the FDA and has received CE Mark approval [3] Conference Participation - The Scripps Structural Heart course is a leading educational forum featuring live case-based reviews, where the LockeT device will be demonstrated, showcasing its role in improving workflow efficiency and patient recovery [2][3] Leadership Statement - The CEO of Catheter Precision expressed pride in having LockeT featured at a prestigious clinical event, indicating the company's momentum and expansion into major medical centers [3]